Aflibercept (Regeneron, USA) · Oncology, Ophthalmology Aflibercept is a soluble decoy receptor that binds and neutralizes vascular endothelial growth factor (VEGF) and placental growth factor (PlGF), inhibiting angiogenesis and vascular permeability.
Cetuximab + FOLFIRI · Oncology Cetuximab blocks EGFR signaling while FOLFIRI chemotherapy damages DNA, together targeting colorectal cancer cells through dual mechanisms.
CinnaPoietin® · Hematology/Oncology CinnaPoietin is an erythropoiesis-stimulating agent that mimics erythropoietin to stimulate red blood cell production.
CinnaTropin® · Endocrinology CinnaTropin® is a recombinant human growth hormone that binds to growth hormone receptors to promote growth, metabolism, and body composition changes.
Interferon Beta-1A Prefilled Syringe · Immunology Interferon Beta-1A binds to type I interferon receptors on cell surfaces to activate antiviral and immunomodulatory pathways.
Nordilet® · Diabetes Nordilet is a dipeptidyl peptidase-4 (DPP-4) inhibitor, which increases the levels of incretin hormones to enhance glucose-dependent insulin secretion.
Ocrelizumab (CinnaGen, Iran) · Immunology Ocrelizumab is a monoclonal antibody that targets and depletes CD20-positive B cells.
Omalizumab (CinnaGen) · Immunology / Allergy Omalizumab is a monoclonal antibody that binds to circulating immunoglobulin E (IgE), preventing its interaction with high-affinity IgE receptors on mast cells and basophils.
Pegylated interferon beta-1a · Immunology Pegylated interferon beta-1a works by stimulating the body's immune system to fight multiple sclerosis.